These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3298415)

  • 21. Effect of captopril and angiotensin II receptor blockade on pressure natriuresis in transgenic TGR(mRen-2)27 rats.
    Gross V; Lippoldt A; Schneider W; Luft FC
    Hypertension; 1995 Sep; 26(3):471-9. PubMed ID: 7649584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refractory ascites: modulation of atrial natriuretic factor unresponsiveness by mannitol.
    Morali GA; Tobe SW; Skorecki KL; Blendis LM
    Hepatology; 1992 Jul; 16(1):42-8. PubMed ID: 1535608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites.
    López C; Jiménez W; Arroyo V; La Villa G; Gaya J; Clària J; Rivera F; Rodés J
    J Hepatol; 1989 Sep; 9(2):217-26. PubMed ID: 2530268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative acute effects of diflunisal and indomethacin on renal function in patients with cirrhosis and ascites.
    Antillon M; Cominelli F; Reynolds TB; Zipser RD
    Am J Gastroenterol; 1989 Feb; 84(2):153-5. PubMed ID: 2916525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic value of the renin-angiotensin system in response to salt restriction and prognosis of alcoholic ascitic cirrhosis].
    Genoud E; Gonvers JJ; Schaller MD; Essinger A; Haller E; Brunner HR
    Schweiz Med Wochenschr; 1986 Apr; 116(15):463-9. PubMed ID: 3518053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
    Zhang X; Dunham EW; Zimmerman BG
    J Hypertens; 1995 Dec; 13(12 Pt 1):1413-19. PubMed ID: 8866903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings.
    Floras JS; Legault L; Morali GA; Hara K; Blendis LM
    Ann Intern Med; 1991 Mar; 114(5):373-80. PubMed ID: 1992879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the renal nerves and angiotensin II in the renal function curve.
    Golin R; Genovesi S; Castoldi G; Wijnmaalen P; Protasoni G; Zanchetti A; Stella A
    Arch Ital Biol; 1999 Aug; 137(4):289-97. PubMed ID: 10443320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal effects of angiotensin II inhibition during increases in renal venous pressure.
    Fiksen-Olsen MJ; Strick DM; Hawley H; Romero JC
    Hypertension; 1992 Feb; 19(2 Suppl):II137-41. PubMed ID: 1735568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition.
    Good JM; Brady AJ; Noormohamed FH; Oakley CM; Cleland JG
    Circulation; 1994 Jul; 90(1):220-4. PubMed ID: 8026000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal hemodynamics and the renin--angiotensin system in cirrhosis: relationship to sodium retention.
    Rosoff L; Williams J; Moult P; Williams H; Sherlock S
    Dig Dis Sci; 1979 Jan; 24(1):25-32. PubMed ID: 428287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
    Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
    Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interrelationships between systemic hemodynamics, urinary sodium excretion, and renin-angiotensin system in cirrhosis.
    Aliaga L; Zozoya JM; Omar M; Mediavilla JD; Prieto J
    Acta Gastroenterol Belg; 1995; 58(2):213-21. PubMed ID: 7571982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term administration of isosorbide-5-mononitrate does not impair renal function in cirrhotic patients.
    Salerno F; Borroni G; Lorenzano E; Solenghi D; Cazzaniga M; Bissoli F; Ceriani R; deFranchis R
    Hepatology; 1996 May; 23(5):1135-40. PubMed ID: 8621145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of a converting enzyme inhibitor (captopril) and angiotensin II on fetal renal function.
    Lumbers ER; Burrell JH; Menzies RI; Stevens AD
    Br J Pharmacol; 1993 Oct; 110(2):821-7. PubMed ID: 8242257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.